Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cambridge Cognition: Bringing objectivity to mental health diagnosis

This article was originally published in Clinica

Executive Summary

While significant advances have been made in the treatment of mental illness, the assessment and diagnosis of mental disorders still relies largely on "paper-and-pencil" tests. Many of these were devised several decades ago and are time-consuming, for both the patient and the assessor, as well as notoriously error-prone. However, the mental health sector could soon witness a paradigm shift, according to oneUK company that is preparing to launch a computerised cognitive testing technology to the clinical diagnostic market next year.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT042285

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel